BridgeMD
New treatment option for Driving Under the Influence of Cannabis
Official title Pilot-Study for the Comparison of Biomarkers Between Regular Cannabis Users and Non-Users
ClinicalTrials.gov ID: NCT06975020
What this study is testing
What is Participants will prepare their cannabis product ad libitum and inhale the prepared product as usual for a maximum of 15 minutes.?
Participants will prepare their cannabis product ad libitum and inhale the prepared product as usual for a maximum of 15 minutes. is an investigational medicine, given as an inhaled treatment, being studied as a potential treatment for driving under the influence of cannabis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The relevance of driving under the influence of cannabis is becoming increasingly important in the context of legalization. However, the measurement of tetrahydrocannabinol (THC) blood concentration is an inadequate marker for assessing driving impairment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Experience of smoking cannabis products, on average once a week. This may be in combination with tobacco.
- Age 18-65 years Possession of driving license in at least one of the categories A, B, A1; B1, F, G or M
- Sufficient knowledge of German
- No cannabis inhalation or nicotine consumption on study day
- No alcohol consumption within the last 24 h
You likely can't join if
- Participation in a trial with investigational drugs within 30 days
- Current or previous major psychiatric disorder (e.g., major depression, schizophrenia spectrum disorder)
- Pregnancy or breastfeeding
- Intake of CYP2C9, CYP2C19, and CYP3A4-inducers in the last 4 weeks before the study visit, e.g. rifampicin (antibiotic), carbamazepine...
- The following conditions: vasopressin deficiency, pituitary tumor, active malignancy, severe hyponatremia requiring treatment, congestive heart...
The study team makes the final eligibility decision.
Where it's taking place
- Basel, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Basel, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.